Elizabeth McKenna: Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers
Elizabeth McKenna shared a post on X about a recent paper by Jamie Medina et al. published in Cancer Discovery.
“Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers”
Authors: Jamie Medina, Akshaya Annapragada, Pien Lof, Christine Lok, Victor Velculescu et al.
“Now online in Cancer Discovery: Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers – by Jamie Medina, Akshaya Annapragada, Jillian Phallen, Christine Lok, Victor Velculescu and colleagues.”
Source: Elizabeth McKenna/X
More posts featuring Elizabeth McKenna on oncodaily.com
Elizabeth McKenna is the Executive Director of Cancer Discovery at the American Association for Cancer Research. Elizabeth earned her PhD from Harvard University and trained with Dr. Charles Roberts at the Dana-Farber Cancer Institute.
Her research was among the first to show that pediatric tumors characterized by mutations in chromatin remodelers are genomically stable and instead driven by epigenetic deregulation of key target genes. She joined Cancer Discovery shortly after its launch as its founding Science Writer and became an editor in 2014, rising through the editorial ranks to become the journal’s Executive Editor in 2019. She is a member of the 40 Under 40 in Cancer Class of 2021.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023